Cargando…
Succinate dehydrogenase‐deficient malignant paraganglioma complicated by succinate dehydrogenase‐deficient renal cell carcinoma
INTRODUCTION: SDH Gene mutation is known to be a common cause of pheochromocytoma/paraganglioma and renal cell carcinoma. Here, we report a case of succinate dehydrogenase B‐deficient paraganglioma, which has a high risk of metastasis and recurrence, complicated by succinate dehydrogenase‐deficient...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626355/ https://www.ncbi.nlm.nih.gov/pubmed/36341179 http://dx.doi.org/10.1002/iju5.12520 |
_version_ | 1784822713458622464 |
---|---|
author | Yamaguchi, Yoshitomo Yokoyama, Minato Takemoto, Akira Nakamura, Yuki Fukuda, Shohei Uehara, Sho Tanaka, Hajime Yoshida, Soichiro Matsuoka, Yoh Fujii, Yasuhisa |
author_facet | Yamaguchi, Yoshitomo Yokoyama, Minato Takemoto, Akira Nakamura, Yuki Fukuda, Shohei Uehara, Sho Tanaka, Hajime Yoshida, Soichiro Matsuoka, Yoh Fujii, Yasuhisa |
author_sort | Yamaguchi, Yoshitomo |
collection | PubMed |
description | INTRODUCTION: SDH Gene mutation is known to be a common cause of pheochromocytoma/paraganglioma and renal cell carcinoma. Here, we report a case of succinate dehydrogenase B‐deficient paraganglioma, which has a high risk of metastasis and recurrence, complicated by succinate dehydrogenase‐deficient renal cell carcinoma, which is rare and accounts for approximately 0.1% of all renal cell carcinomas. CASE PRESENTATION: A 50‐year‐old man underwent en bloc resection of a retroperitoneal tumor and the right kidney for retroperitoneal paraganglioma and right renal tumor. Both tumors showed negative expressions of succinate dehydrogenase B in immunostaining. The patient was diagnosed with succinate dehydrogenase‐deficient paraganglioma and succinate dehydrogenase‐deficient renal cell carcinoma. Seventeen months later, retroperitoneal lymphadenectomy revealed lymph node metastasis of the paraganglioma. Deletion of the SDHB gene was revealed by genome sequencing of the lymph node. CONCLUSION: This is the first reported case of synchronously diagnosed succinate dehydrogenase‐deficient paraganglioma and succinate dehydrogenase‐deficient renal cell carcinoma. |
format | Online Article Text |
id | pubmed-9626355 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96263552022-11-03 Succinate dehydrogenase‐deficient malignant paraganglioma complicated by succinate dehydrogenase‐deficient renal cell carcinoma Yamaguchi, Yoshitomo Yokoyama, Minato Takemoto, Akira Nakamura, Yuki Fukuda, Shohei Uehara, Sho Tanaka, Hajime Yoshida, Soichiro Matsuoka, Yoh Fujii, Yasuhisa IJU Case Rep Case Reports INTRODUCTION: SDH Gene mutation is known to be a common cause of pheochromocytoma/paraganglioma and renal cell carcinoma. Here, we report a case of succinate dehydrogenase B‐deficient paraganglioma, which has a high risk of metastasis and recurrence, complicated by succinate dehydrogenase‐deficient renal cell carcinoma, which is rare and accounts for approximately 0.1% of all renal cell carcinomas. CASE PRESENTATION: A 50‐year‐old man underwent en bloc resection of a retroperitoneal tumor and the right kidney for retroperitoneal paraganglioma and right renal tumor. Both tumors showed negative expressions of succinate dehydrogenase B in immunostaining. The patient was diagnosed with succinate dehydrogenase‐deficient paraganglioma and succinate dehydrogenase‐deficient renal cell carcinoma. Seventeen months later, retroperitoneal lymphadenectomy revealed lymph node metastasis of the paraganglioma. Deletion of the SDHB gene was revealed by genome sequencing of the lymph node. CONCLUSION: This is the first reported case of synchronously diagnosed succinate dehydrogenase‐deficient paraganglioma and succinate dehydrogenase‐deficient renal cell carcinoma. John Wiley and Sons Inc. 2022-08-03 /pmc/articles/PMC9626355/ /pubmed/36341179 http://dx.doi.org/10.1002/iju5.12520 Text en © 2022 The Authors. IJU Case Reports published by John Wiley & Sons Australia, Ltd on behalf of Japanese Urological Association. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Reports Yamaguchi, Yoshitomo Yokoyama, Minato Takemoto, Akira Nakamura, Yuki Fukuda, Shohei Uehara, Sho Tanaka, Hajime Yoshida, Soichiro Matsuoka, Yoh Fujii, Yasuhisa Succinate dehydrogenase‐deficient malignant paraganglioma complicated by succinate dehydrogenase‐deficient renal cell carcinoma |
title | Succinate dehydrogenase‐deficient malignant paraganglioma complicated by succinate dehydrogenase‐deficient renal cell carcinoma |
title_full | Succinate dehydrogenase‐deficient malignant paraganglioma complicated by succinate dehydrogenase‐deficient renal cell carcinoma |
title_fullStr | Succinate dehydrogenase‐deficient malignant paraganglioma complicated by succinate dehydrogenase‐deficient renal cell carcinoma |
title_full_unstemmed | Succinate dehydrogenase‐deficient malignant paraganglioma complicated by succinate dehydrogenase‐deficient renal cell carcinoma |
title_short | Succinate dehydrogenase‐deficient malignant paraganglioma complicated by succinate dehydrogenase‐deficient renal cell carcinoma |
title_sort | succinate dehydrogenase‐deficient malignant paraganglioma complicated by succinate dehydrogenase‐deficient renal cell carcinoma |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626355/ https://www.ncbi.nlm.nih.gov/pubmed/36341179 http://dx.doi.org/10.1002/iju5.12520 |
work_keys_str_mv | AT yamaguchiyoshitomo succinatedehydrogenasedeficientmalignantparagangliomacomplicatedbysuccinatedehydrogenasedeficientrenalcellcarcinoma AT yokoyamaminato succinatedehydrogenasedeficientmalignantparagangliomacomplicatedbysuccinatedehydrogenasedeficientrenalcellcarcinoma AT takemotoakira succinatedehydrogenasedeficientmalignantparagangliomacomplicatedbysuccinatedehydrogenasedeficientrenalcellcarcinoma AT nakamurayuki succinatedehydrogenasedeficientmalignantparagangliomacomplicatedbysuccinatedehydrogenasedeficientrenalcellcarcinoma AT fukudashohei succinatedehydrogenasedeficientmalignantparagangliomacomplicatedbysuccinatedehydrogenasedeficientrenalcellcarcinoma AT ueharasho succinatedehydrogenasedeficientmalignantparagangliomacomplicatedbysuccinatedehydrogenasedeficientrenalcellcarcinoma AT tanakahajime succinatedehydrogenasedeficientmalignantparagangliomacomplicatedbysuccinatedehydrogenasedeficientrenalcellcarcinoma AT yoshidasoichiro succinatedehydrogenasedeficientmalignantparagangliomacomplicatedbysuccinatedehydrogenasedeficientrenalcellcarcinoma AT matsuokayoh succinatedehydrogenasedeficientmalignantparagangliomacomplicatedbysuccinatedehydrogenasedeficientrenalcellcarcinoma AT fujiiyasuhisa succinatedehydrogenasedeficientmalignantparagangliomacomplicatedbysuccinatedehydrogenasedeficientrenalcellcarcinoma |